VivoSeq
Other

Frailty

2

Pipeline Programs↗

9

Active Trials↗

2

Companies Involved↗

Frailty is an early-stage landscape with 2 programs across 2 companies. The most active players are Xenon Pharmaceuticals Inc., Universidad de Almeria.

Intelligence

Pipeline Metrics

Competitive Density

30/100

Pipeline Velocity

25/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

X

Xenon Pharmaceuticals Inc.

1 program

Phase 2U

Universidad de Almeria

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 22

Epigallocatechin-3-Gallate

University of Rochester

Microcrystalline Cellulose

Xenon Pharmaceuticals Inc.

Phase 3
No programs
Approved
No programs

Analysis

Trial Status

16

clinical trials

Recruiting5 · 31%
Completed4 · 25%
Suspended2 · 13%
Not yet recruiting2 · 13%
Active, not recruiting2 · 13%
Unknown status1 · 6%

Clinical Trials

Trial Activity

16 trials

Orthopedic Procedures and Postoperative Delirium in the Czech Republic
Recruiting·TTomas Bata Hospital, Czech Republic·N/A·NCT07432009·400 enrolled
The BHFS Study (Better, Harder, Faster, Stronger): Does Neoadjuvant Chemotherapy Improve Fitness for Surgery?
Recruiting·WWake Forest University Health Sciences·N/A·NCT07220512·35 enrolled
The Effect of Perioperative Prehabilitation on Markers of Fitness and Frailty in Patients Undergoing Elective Surgery: a Pilot, Pragmatic, Randomized Controlled Trial
Recruiting·UUniversity of Alberta·Preclinical·NCT05977556·50 enrolled
SAGE-Heart : Senior Assessment fraGility and Post-opErative QALYs 1 Year After Emergency HEART Surgery for Patients Aged 75 and Older
Recruiting·UUniversity Hospital, Bordeaux·Preclinical·NCT07677319·265 enrolled
Impact of Auditory Stimulation in Eating Pleasure : Multicentric Study With Biscuits With Crunchy Texture vs Soft Texture in 100 Seniors Affected or at Risk of Presbyacusis
Recruiting·CCentre Hospitalier Universitaire de Nice·N/A·NCT04923087·100 enrolled
Feasibility of a Multidisciplinary Intervention Programme Carried Out by Nursing and Physical Activity and Sports Sciences Students to Improve Frailty and Other Related Variables in Older Adults Living in Nursing Homes.
Active, not recruiting·UUniversidad de Almeria·Preclinical·NCT07182747·60 enrolled
Remote Exercise Video Adaptations to Maximize Physical Activity in Childhood Cancer
Active, not recruiting·SSt. Jude Children's Research Hospital·N/A·NCT06411704·10 enrolled
A Study of Human Allogeneic Bone-marrow-derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Aging Frailty
Not yet recruiting·CCellcolabs Clinical LTD.·Phase 1/2·NCT06070532·12 enrolled
The SHAPE Project (Hospital System for Physical Activity and Active Participation) After Hospitalized Decompensation of Respiratory Chronic Disease in Respiratory Patients
Not yet recruiting·HHospital Universitari de Bellvitge·Preclinical·NCT07663955·90 enrolled
Reducing Frailty for Older Cancer Survivors Using Supplements
Completed·UUniversity of Rochester·Phase 2·NCT04553666·24 enrolled
Frailty and Gallbladder Diseases Complications
Completed·ZZagazig University·Preclinical·NCT07696078
Combinatorial Approach of Connected Functions for Multimodal Health Data Collection
Completed·RRennes University Hospital·Preclinical·NCT04514536·34 enrolled
Effect of Resistance-Led Multicomponent Training Combined With Nutritional Supplementation on Intrinsic Capacity and Disability Risk in Chinese Rural Older Adults
Completed·Capital University of Physical Education and Sports, China·Preclinical·NCT07660653·220 enrolled
Autologous Stem/Stromal Cellular Stromal Vascular Fraction (cSVF) In Frailty-Aging Processes
Suspended·HHealeon Medical Inc·N/A·NCT03514537·200 enrolled
A Phase 2 Randomized Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Frailty and Inflammation in Older Survivors of Cancer
Suspended·UUniversity of Rochester·Phase 2·NCT06068543·118 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)